BioNTech and Pfizer Hope to Have Late-Stage Coronavirus Vaccine Results by October

On Tuesday, BioNTech (NASDAQ: BNTX) confirmed what its big pharma partner, Pfizer (NYSE: PFE), had already let out of the bag: The companies hope to have phase 3 results for their coronavirus vaccine candidate by October.

In late July, the duo selected the best vaccine from its early candidates to take into phase 2b/3 development and started the study shortly thereafter. Once the clinical trial is fully enrolled and all of the approximately 30,000 subjects have received the vaccine and placebo, it'll take another 21 days before the subjects will get their booster shots.

Assuming the drugmakers wrap up enrollment in the next week or so, the last booster for the final patient would be given in the middle of September. That doesn't give much time before the self-imposed expectations for data in October.

Source Fool.com